| PTO Form 1478 (Rev 9/2006) |
| OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
| Serial Number: 85914704 |
| Filing Date: 04/25/2013 |
NOTE: Data fields with the * are mandatory under TEAS Plus. The wording "(if applicable)" appears where the field is only mandatory under the facts of the particular
application.
The table below presents the data as entered.
Input Field
|
Entered
|
| TEAS Plus |
YES |
| MARK INFORMATION |
| *MARK |
EJECTDELAY |
| *STANDARD CHARACTERS |
YES |
| USPTO-GENERATED IMAGE |
YES |
| LITERAL ELEMENT |
EJECTDELAY |
| *MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font, style, size, or color. |
| REGISTER |
Principal |
| APPLICANT INFORMATION |
| *OWNER OF MARK |
Innovus Pharmaceuticals, Inc. |
| *STREET |
4275 Executive Square, Suite 200 |
| *CITY |
La Jolla |
*STATE
(Required for U.S. applicants) |
California |
| *COUNTRY |
United States |
*ZIP/POSTAL CODE
(Required for U.S. applicants only) |
92037 |
| EMAIL ADDRESS |
XXXX |
| AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
| LEGAL ENTITY INFORMATION |
| *TYPE |
CORPORATION |
| * STATE/COUNTRY OF INCORPORATION |
Nevada |
| GOODS AND/OR SERVICES AND BASIS INFORMATION |
| *INTERNATIONAL CLASS |
005 |
| *IDENTIFICATION |
Pharmaceutical preparations for use in urology; Pharmaceutical preparations for maintaining ejaculatory control and/or sexual
sensation; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction |
| *FILING BASIS |
SECTION 1(b) |
| ADDITIONAL STATEMENTS INFORMATION |
*TRANSLATION
(if applicable) |
|
*TRANSLITERATION
(if applicable) |
|
*CLAIMED PRIOR REGISTRATION
(if applicable) |
|
*CONSENT (NAME/LIKENESS)
(if applicable) |
|
*CONCURRENT USE CLAIM
(if applicable) |
|
| CORRESPONDENCE INFORMATION |
| *NAME |
Innovus Pharmaceuticals, Inc. |
| FIRM NAME |
Innovus Pharmaceuticals, Inc. |
| *STREET |
4275 Executive Square, Suite 200 |
| *CITY |
La Jolla |
*STATE
(Required for U.S. applicants) |
California |
| *COUNTRY |
United States |
| *ZIP/POSTAL CODE |
92037 |
| *EMAIL ADDRESS |
jshaffer@innovuspharma.com |
| *AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
| FEE INFORMATION |
| NUMBER OF CLASSES |
1 |
| FEE PER CLASS |
275 |
| *TOTAL FEE PAID |
275 |
| SIGNATURE INFORMATION |
| * SIGNATURE |
/Bassam Damaj/ |
| * SIGNATORY'S NAME |
Bassam Damaj |
| * SIGNATORY'S POSITION |
CEO |
| * DATE SIGNED |
04/25/2013 |
| PTO Form 1478 (Rev 9/2006) |
| OMB No. 0651-0009 (Exp 12/31/2014) |
Trademark/Service Mark Application, Principal Register
TEAS Plus Application
| Serial Number: 85914704 |
| Filing Date: 04/25/2013 |
To the Commissioner for Trademarks:
MARK: EJECTDELAY (Standard Characters, see
mark)
The literal element of the mark consists of EJECTDELAY.
The mark consists of standard characters, without claim to any particular font, style, size, or color.
The applicant, Innovus Pharmaceuticals, Inc., a corporation of Nevada, having an address of
4275 Executive Square, Suite 200
La Jolla, California 92037
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Pharmaceutical preparations for use in urology; Pharmaceutical preparations for maintaining ejaculatory control and/or sexual
sensation; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction
Intent to Use: The applicant has a bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with the identified goods and/or
services. (15 U.S.C. Section 1051(b)).
| The applicant's current Correspondence Information: |
| Innovus Pharmaceuticals, Inc. |
| Innovus Pharmaceuticals, Inc. |
| 4275 Executive Square, Suite 200 |
| La Jolla, California 92037 |
| jshaffer@innovuspharma.com (authorized) |
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false
statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the
applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes
applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either
in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake,
or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.
Signature: /Bassam Damaj/ Date Signed: 04/25/2013
Signatory's Name: Bassam Damaj
Signatory's Position: CEO
RAM Sale Number: 85914704
RAM Accounting Date: 04/26/2013
Serial Number: 85914704
Internet Transmission Date: Thu Apr 25 14:49:21 EDT 2013
TEAS Stamp: USPTO/FTK-XX.XXX.XXX.XXX-201304251449210
72911-85914704-500fd1365f3c6478ded354994
dae48ef0339dad8a983e216a3e115b7679c1b49a
b-CC-1049-20130425144640147554
